M&T Bank
ROIV icon

M&T Bank’s Roivant Sciences ROIV Stock Holding History

M&T Bank’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$599K Buy
16,913
+587
+4% +$17.3K ﹤0.01% 1121
2026
Q1 		$453K Buy
16,326
+3,036
+23% +$78K ﹤0.01% 1177
2025
Q4 		$288K Buy
+13,290
New +$262K ﹤0.01% 1415
2025
Q3 		– Sell
-12,802
Closed -$144K – 1587
2025
Q2 		$144K Buy
12,802
+1,181
+10% +$12.8K ﹤0.01% 1475
2025
Q1 		$117K Sell
11,621
-1,573
-12% -$17K ﹤0.01% 1467
2024
Q4 		$156K Buy
13,194
+1,851
+16% +$21.9K ﹤0.01% 1551
2024
Q3 		$131K Buy
+11,343
New +$129K ﹤0.01% 1549

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

M&T Bank's ROIV Position: Q2 2026 in Review

M&T Bank increased its Roivant Sciences (ROIV) stake by 3.6% in Q2 2026, buying an estimated $17.3K and bringing the position to 16,913 shares worth $599K. The position accounts for ﹤0.01% of the portfolio, ranked #1121.

M&T Bank first reported a position in ROIV in Q3 2024 and has held it in 7 quarters since. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • M&T Bank held 16,913 shares of Roivant Sciences worth $599K as of Q2 2026.
  • M&T Bank bought 587 Roivant Sciences shares in Q2 2026, an estimated $17.3K.
  • Roivant Sciences made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #1121 holding.
  • M&T Bank first reported a position in Roivant Sciences in Q3 2024 and has held it in 7 quarters since.
  • 500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.